MAIA Biotechnology, Inc.·4

Feb 12, 4:10 PM ET

Vitoc Vlad 4

4 · MAIA Biotechnology, Inc. · Filed Feb 12, 2025

Insider Transaction Report

Form 4
Period: 2025-02-10
Vitoc Vlad
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Stock Options

    2025-02-10+400,000400,000 total
    Exercise: $1.81Exp: 2035-02-10Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]The stock options, granted on February 10, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT